Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Keller announces buyback after strong 2024 profit growth

(Sharecast News) - The share price of Keller surged on Tuesday after the geotechnical engineering company reported a big increase in underlying annual profits that beat market expectations and a share buyback programme, bolstered by a record year-end order book. Revenues were just 1% higher in 2024 at £2.99bn, but would have been 4% higher at constant currency.

North American revenues, which make up the bulk of the business, increased 4.2% at constant currency to £1.79bn, driven by improved trading in the foundations business. In Europe and the Middle East, revenues were up 5.5% at £835m, reflecting an improved performance in Europe and the completion of a large infrastructure project in Central Europe.

That helped to offset a 2.1% revenue decline in Asia Pacific to £366m, due to a "moderation of trading volume" in Australia following a strong performance in 2023, as well as lower volumes at the Austral unit.

Underlying operating profits were up 22% on a constant currency basis at £213m, helped by a 100-basis point improvement in the underlying operating profit margin to 7.1%.

Meanwhile, free cash flow generation increased by 87% to £193m, while net debt was slashed by £117m to £30m.

The company ended the year with a record order book of £1.6bn, up from £1.5bn at the end of 2023.

As well as a 10% increase in the total dividend to 49.7p, Keller said it was launching a multi-year share buyback programme, with an initial tranche of £25m in the first quarter.

"2024 was another outstanding year for Keller, ahead of expectations, delivering improved performance across all key metrics - profits, earnings, margin, return on capital, cash conversion and debt reduction," said chief executive Michael Speakman.

Shares were up nearly 14% at 1,468p by 1047 GMT.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.